Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07069868 · ClinicalTrials.gov registry record · NA
Telehealth in an Ambulatory Oncology Phase I Clinical Trial Unit
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT07069868: Completed NA study, sponsored by Massachusetts General Hospital.
NCT07069868 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 21 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07069868, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
The study aimed to evaluate the feasibility, acceptability, satisfaction and effectiveness of telehealth on early identification and mitigation of adverse events during cycle one of a Phase 1 oncology clinical trial.
Interventions
- OTHER Telehealth
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2021-08-12 |
| Est. Completion | 2022-03-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07069868
The ClinicalTrials.gov registry entry for NCT07069868 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Telehealth is the first listed.
NCT07069868 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07069868 about?
NCT07069868 is a clinical study titled "Telehealth in an Ambulatory Oncology Phase I Clinical Trial Unit". The study aimed to evaluate the feasibility, acceptability, satisfaction and effectiveness of telehealth on early identification and mitigation of adverse events during cycle one of a Phase 1 oncology clinical trial.
What is the current status of trial NCT07069868?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2021-08-12. Estimated completion is 2022-03-24.
What interventions are being tested in trial NCT07069868?
The interventions under investigation include: Telehealth (OTHER).
Who is sponsoring clinical trial NCT07069868?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.